Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33M
-
Number of holders
-
310
-
Total 13F shares, excl. options
-
29.8M
-
Shares change
-
+893K
-
Total reported value, excl. options
-
$5.14B
-
Value change
-
+$164M
-
Put/Call ratio
-
0.88
-
Number of buys
-
178
-
Number of sells
-
-138
-
Price
-
$172.29
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q1 2022
384 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q1 2022.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 310 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.8M shares
of 33M outstanding shares and own 90.47% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.9M shares), VANGUARD GROUP INC (3.05M shares), WELLINGTON MANAGEMENT GROUP LLP (1.88M shares), RIVERBRIDGE PARTNERS LLC (1.69M shares), AMERIPRISE FINANCIAL INC (1.52M shares), JPMORGAN CHASE & CO (1.38M shares), MACKENZIE FINANCIAL CORP (957K shares), PRICE T ROWE ASSOCIATES INC /MD/ (915K shares), STATE STREET CORP (871K shares), and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (720K shares).
This table shows the top 310 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.